Sernova Corp., a health sciences company, engages in the development and commercialization of medical technologies in the cell therapy arena primarily in the United States and Canada. The company develops implantable medical devices for the treatment of chronic diseases using therapeutic cells. Its proprietary platform technologies include Cell Pouch System, a device providing a natural organ-like environment for therapeutic cells, such as insulin producing islets for diabetics; and Sertolin, a cell-based technology providing an immune-privileged environment for donor cells, reducing or eliminating the need for anti-rejection drugs.